SCHEMBL7977845

SCHEMBL7977845

CCC1(CC)C(=O)N[C@@H]1Oc1ccc(C(=O)N2CCN(C)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.49
▸ POLB P06746 4/20 0.45
▸ F2 P00734 1/20 0.45
▸ ELANE P08246 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ HPGD P15428 7/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ HRH3 Q9Y5N1 1/20 0.42
▸ EPHX2 P34913 1/20 0.42
▸ KMT2A Q03164 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6430758 1.00 NPC1 (0.49) NPC1POLBF2ELANEALDH1A1
SCHEMBL8605725 0.79 ELANE (0.41) ELANEALDH1A1KMT2ATSHR
SCHEMBL8605131 0.79 ELANE (0.41) ELANEALDH1A1KMT2ATSHR
SCHEMBL7372508 0.79 LMNA (0.43) POLBALDH1A1HPGDGAAL3MBTL1
SCHEMBL6430759 0.78 JAK2 (0.38) ALDH1A1HPGDGAAHRH3KMT2A
SCHEMBL7371447 0.74 CA12 (0.36) POLBELANEALDH1A1HSD17B10ALOX15
SCHEMBL7429786 0.72 ELANE (0.43) POLBELANEALDH1A1HSD17B10HPGD
SCHEMBL6431725 0.71 ELANE (0.57) NPC1POLBF2ELANEALDH1A1
SCHEMBL10724841 0.71 POLB (0.81) NPC1POLBALDH1A1HPGDALOX15
SCHEMBL6431149 0.70 ELANE (0.56) NPC1POLBF2ELANEHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194569-B1 REACTING AZETIDINE CARBOXAMIDE COMPOUND WITH PIPERAZINE COMPOUND IN PRESENCE OF AQUEOUS BASE AND PHASE TRANSFER CATALYST DUPONT PHARMACEUTICALS COMPANY 2001-02-27 — — US disclosed
Send feedback